nefazodone has been researched along with Recrudescence in 19 studies
nefazodone: may be useful as an opiate adjunct
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study evaluates the safety and efficacy of nefazodone in patients with major depressive disorder (MDD) in comparison to imipramine and placebo treatments." | 5.07 | A double-blind comparison of nefazodone, imipramine, and placebo in major depression. ( Ecker, JA; Elie, R; Faludi, G; Fontaine, R; Kaplita, S; Kensler, TT; Ontiveros, A; Roberts, DL, 1994) |
| "Maintenance treatment to prevent recurrences is recommended for chronic forms of major depressive disorder (MDD), but few studies have examined maintenance efficacy of antidepressants with chronic MDD." | 2.71 | Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. ( Arnow, B; Banks, P; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Howland, R; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Munsaka, M; Rothbaum, B; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J, 2003) |
| " Assessments included Clinical Global Impression Scales, Hamilton Rating Scales for Depression and Anxiety, Montgomery-Asberg Depression Rating Scale and the Patient Global Assessment Scale, in addition to a review of reported adverse events, vital sign measurements, electrocardiograms and clinical laboratory tests." | 2.70 | A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment. ( Baldwin, DS; Hawley, CJ; Mellors, K, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maddux, RE | 1 |
| Riso, LP | 2 |
| Klein, DN | 3 |
| Markowitz, JC | 3 |
| Rothbaum, BO | 1 |
| Arnow, BA | 1 |
| Manber, R | 3 |
| Blalock, JA | 2 |
| Keitner, GI | 2 |
| Thase, ME | 3 |
| Ehrentraut, S | 1 |
| Rothenhäusler, HB | 1 |
| Gerbes, AL | 1 |
| Rau, HG | 1 |
| Thiel, M | 1 |
| Schirren, CA | 1 |
| Kapfhammer, HP | 1 |
| Gelenberg, AJ | 1 |
| Trivedi, MH | 2 |
| Rush, AJ | 1 |
| Howland, R | 1 |
| Kornstein, SG | 1 |
| Dunner, DL | 2 |
| Hirschfeld, RM | 1 |
| Zajecka, J | 1 |
| Kocsis, JH | 1 |
| Russell, JM | 1 |
| Miller, I | 1 |
| Arnow, B | 2 |
| Rothbaum, B | 2 |
| Munsaka, M | 1 |
| Banks, P | 1 |
| Borian, FE | 2 |
| Keller, MB | 3 |
| Schwartz, JE | 1 |
| Santiago, NJ | 1 |
| Vivian, D | 1 |
| Vocisano, C | 1 |
| Castonguay, LG | 1 |
| McCullough, JP | 1 |
| Miller, IW | 1 |
| Nemeroff, CB | 1 |
| Fontaine, R | 1 |
| Ontiveros, A | 1 |
| Elie, R | 1 |
| Kensler, TT | 2 |
| Roberts, DL | 2 |
| Kaplita, S | 1 |
| Ecker, JA | 1 |
| Faludi, G | 1 |
| Marcus, RN | 1 |
| Mendels, J | 1 |
| Montgomery, SA | 2 |
| Baldwin, DS | 2 |
| Hawley, CJ | 2 |
| Abed, RT | 1 |
| Maragakis, BP | 1 |
| Cox, J | 1 |
| Buckingham, SA | 1 |
| Pover, GH | 1 |
| Ascher, A | 1 |
| Brown, RE | 1 |
| Clark, M | 1 |
| Castañeda, R | 1 |
| Levy, R | 1 |
| Westreich, LM | 1 |
| Sussman, N | 1 |
| Feiger, AD | 1 |
| Bielski, RJ | 1 |
| Bremner, J | 1 |
| Heiser, JF | 1 |
| Trivedi, M | 1 |
| Wilcox, CS | 1 |
| McQuade, RD | 2 |
| Kaplita, SB | 1 |
| Archibald, DG | 1 |
| El-Mallakh, RS | 1 |
| Kranzler, HR | 1 |
| Modesto-Lowe, V | 1 |
| Van Kirk, J | 1 |
| Baker, SM | 1 |
| Ferguson, JM | 1 |
| Shrivastava, RK | 1 |
| Stahl, SM | 1 |
| Hartford, JT | 1 |
| Borian, F | 1 |
| Ieni, J | 1 |
| Jody, D | 1 |
| Mellors, K | 1 |
4 reviews available for nefazodone and Recrudescence
| Article | Year |
|---|---|
Evolutionary trends in the pharmacotherapeutic management of depression.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antidepressive Agents; Antidepressive Agents, Tricycl | 1994 |
Efficacy in long-term treatment of depression.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; | 1996 |
Clinical significance of monitoring early symptom change to predict outcome.
Topics: Algorithms; Citalopram; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Pip | 2001 |
Acute and maintenance treatment of chronic depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive B | 2001 |
12 trials available for nefazodone and Recrudescence
| Article | Year |
|---|---|
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cogniti | 2009 |
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; C | 2003 |
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality The | 2003 |
A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admini | 1994 |
Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder | 1996 |
A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double- | 1996 |
Economic analysis of treating depression with nefazodone v. imipramine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; D | 1996 |
Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Fem | 1999 |
Rapid fade of antidepressant effect of nefazodone in bipolar depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Administration Schedule; Fem | 1999 |
Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.
Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Doubl | 2000 |
Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Hu | 2001 |
A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.
Topics: Adult; Aged; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Long | 2001 |
3 other studies available for nefazodone and Recrudescence
| Article | Year |
|---|---|
[Acute liver failure in nefazodone therapy? A case report].
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Fatal Outcome; H | 2002 |
Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Female; Fluox | 1996 |
Long-term treatment of recurrent and chronic depression.
Topics: Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Comb | 2001 |